Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 40,893 | 30,336 | 1,605 | 154 | 250 |
| Cost of Goods | 2,407 | N/A | N/A | N/A | N/A |
| Gross Profit | 38,486 | 30,336 | 1,605 | 154 | 250 |
| Operating Expenses | 228,168 | 210,219 | 132,143 | 110,886 | 119,326 |
| Operating Income | -189,275 | -179,883 | -130,538 | -110,732 | -119,076 |
| Interest Expense | 15,647 | 2,493 | 0 | 0 | 0 |
| Other Income | 5,372 | 3,995 | 1,617 | 1,294 | 895 |
| Pre-tax Income | -199,550 | -178,381 | -128,921 | -109,438 | -118,181 |
| Income Tax | 40 | 26 | 63 | 139 | N/A |
| Net Income Continuous | -199,590 | -178,407 | -128,984 | -109,577 | -118,181 |
| Net Income | $-199,590 | $-178,407 | $-128,984 | $-109,577 | $-118,181 |
| EPS Basic Total Ops | -48.28 | -47.08 | -42.13 | -43.78 | -49.78 |
| EPS Basic Continuous Ops | -48.30 | -47.11 | -42.13 | -43.78 | -49.74 |
| EPS Diluted Total Ops | -48.28 | -47.08 | -42.13 | -43.78 | -49.78 |
| EPS Diluted Continuous Ops | -48.30 | -47.11 | -42.13 | -43.78 | -49.74 |
| EPS Diluted Before Non-Recurring Items | -48.28 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-182,490 | $-177,699 | $-128,638 | $-108,816 | $-116,664 |